BioCentury
ARTICLE | Company News

Qiagen in two microarray deals

August 6, 2001 7:00 AM UTC

Bayer (FSE:BAYG; BAYZY) will have limited access to the ZeptoGene Workstation, a DNA microarray technology from Qiagen (QGENF; NMarkt:QIA). The platform, developed with Zeptosens (Witterswil, Switzerland), is based on Planar Waveguide (PWG) array technology and is designed to allow the use of minimal sample amounts to analyze differential expression patterns of genes expressed at low levels. ...